Medrx Co (TSE:4586) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Medrx Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Medrx Co's Free Cash Flow for the three months ended in Mar. 2024 was 円0.00 Mil. Medrx Co's Revenue for the three months ended in Mar. 2024 was 円0.00 Mil. Therefore, Medrx Co's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Medrx Co's current FCF Yield % is -16.07%.

The historical rank and industry rank for Medrx Co's FCF Margin % or its related term are showing as below:

TSE:4586' s FCF Margin % Range Over the Past 10 Years
Min: -15521.1 Med: -2648.77 Max: -456.48
Current: -4051.92

During the past 13 years, the highest FCF Margin % of Medrx Co was -456.48%. The lowest was -15521.10%. And the median was -2648.77%.

TSE:4586's FCF Margin % is ranked worse than
98.25% of 1028 companies
in the Drug Manufacturers industry
Industry Median: 0.06 vs TSE:4586: -4051.92

Medrx Co FCF Margin % Historical Data

The historical data trend for Medrx Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medrx Co FCF Margin % Chart

Medrx Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1,059.41

-890.38

-11,092.57

-1,807.69

-3,096.63

Medrx Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Medrx Co's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Medrx Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medrx Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medrx Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Medrx Co's FCF Margin % falls into.

Medrx Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Medrx Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-914.559	/	29.534
	=	-3,096.63 %

Medrx Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	0
	=	%

Medrx Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Medrx Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medrx Co (TSE:4586) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medrx Co Ltd (TSE:4586) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712

Website

http://www.medrx.co.jp

Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.

Medrx Co (TSE:4586) Headlines

No Headlines